Literature DB >> 26517761

Transient mixed chimerism for allograft tolerance.

Tetsu Oura1, Kiyohiko Hotta1, A B Cosimi1, Tatsuo Kawai.   

Abstract

Mixed chimerism discovered in Freemartin cattle by Ray Owen 70 years ago paved the way for research on immune tolerance. Since his discovery, significant progress has been made in the effort to induce allograft tolerance via mixed chimerism in various murine models. However, induction of persistent mixed chimerism has proved to be extremely difficult in major histocompatibility complex mismatched humans. Chimerism induced in humans tends to either disappear or convert to full donor chimerism, depending on the intensity of the conditioning regimen. Nevertheless, our studies in both NHPs and humans have clearly demonstrated that renal allograft tolerance can be induced by transient mixed chimerism. Our studies have shown that solid organ allograft tolerance via transient mixed chimerism 1) requires induction of multilineage hematologic chimerism, 2) depends on peripheral regulatory mechanisms, rather than thymic deletion, for long-term maintenance, 3) is organ specific (kidney and lung but not heart allograft tolerance are feasible). A major advantage of tolerance induction via transient mixed chimerism is exclusion of the risk of graft-versus-host disease. Our ongoing studies are directed toward improving the consistency of tolerance induction, reducing the morbidity of the conditioning regimen, substituting clinically available agents, such as Belatacept for the now unavailable anti-CD2 monoclonal antibody, and extending the protocol to recipients of deceased donor allografts.

Entities:  

Keywords:  ATG; Donor BMT; Freemartin cattle; full chimerism; GVHD; HLA-match; HLA-mismatch; NHP; TBI; TI; TLI; TMEM; combined Kidney/BMT; mixed chimerism; multilineage chimerism; neonatal tolerance; nonmyeloablative; operational tolerance; persistent (durable) mixed chimerism; transient mixed chimerism

Mesh:

Year:  2015        PMID: 26517761      PMCID: PMC5064472          DOI: 10.1080/19381956.2015.1111975

Source DB:  PubMed          Journal:  Chimerism        ISSN: 1938-1964


  33 in total

1.  PERSISTENCE OF TOLERANCE TOWARDS DONOR-TYPE ANTIGENS AFTER TEMPORARY CHIMERISM IN RATS.

Authors:  H BALNER
Journal:  Transplantation       Date:  1964-07       Impact factor: 4.939

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

3.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

4.  Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.

Authors:  M Kimikawa; D H Sachs; R B Colvin; A Bartholomew; T Kawai; A B Cosimi
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

5.  THE THEORY OF THE FREE-MARTIN.

Authors:  F R Lillie
Journal:  Science       Date:  1916-04-28       Impact factor: 47.728

6.  An investigation of immunological tolerance based on chimaera analysis.

Authors:  D MICHIE; M F WOODRUFF; I M ZEISS
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

7.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

8.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

9.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

10.  Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance.

Authors:  T Wekerle; M H Sayegh; J Hill; Y Zhao; A Chandraker; K G Swenson; G Zhao; M Sykes
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  5 in total

1.  Induction of Tolerance Towards Solid Organ Allografts Using Hematopoietic Cell Transplantation in Large Animal Models.

Authors:  Scott S Graves; David W Mathes; Rainer Storb
Journal:  OBM Transplant       Date:  2019-08-23

Review 2.  Recent Progress in Cell Therapy in Solid Organ Transplantation.

Authors:  R Garakani; R F Saidi
Journal:  Int J Organ Transplant Med       Date:  2017-08-01

Review 3.  Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Stem Cells Transl Med       Date:  2017-01-03       Impact factor: 6.940

4.  Manipulating adrenergic stress receptor signalling to enhance immunosuppression and prolong survival of vascularized composite tissue transplants.

Authors:  Minhyung Kim; Daniel T Fisher; Paul N Bogner; Umesh Sharma; Han Yu; Joseph J Skitzki; Elizabeth A Repasky
Journal:  Clin Transl Med       Date:  2022-08

5.  Stability of Chimerism in Non-Obese Diabetic Mice Achieved By Rapid T Cell Depletion Is Associated With High Levels of Donor Cells Very Early After Transplant.

Authors:  Jiaxin Lin; William F N Chan; Louis Boon; Colin C Anderson
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.